JCCP Guidance Statement – Responsible Prescribing for Cosmetic Procedures

 

The recent aesthetic sector licencing amendment contained within the Health and Care Act (2022) and the enactment of the Botulinum Toxins and Cosmetic Fillers (Children) Act (2021 have caused prescribing in cosmetic procedures to come under close scrutiny.

To read our full statement click here

Your session timed-out.

Please Re-Login to Continue.

You have chosen invalid value.

We cannot continue with your application at this time.

Currently you do not meet the criteria to join the JCCP register and we cannot continue with your application at this time.